v3.26.1
Acquisitions and Divestitures (Tables) - 908 Devices Inc. Bioprocessing Analytics Portfolio
 6 Months Ended
Jun. 30, 2026
Business Combination [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents

 

$

191

 

Accounts receivable

 

 

1,110

 

Inventory

 

 

6,946

 

Prepaid expenses and other current assets

 

 

651

 

Property and equipment

 

 

1,698

 

Operating lease right of use assets

 

 

2,552

 

Other assets, long-term

 

 

41

 

Customer relationships

 

 

5,040

 

Developed technology

 

 

6,910

 

Trademark and tradename

 

 

1,660

 

Goodwill

 

 

50,177

 

Accounts payable

 

 

(208

)

Accrued liabilities

 

 

(542

)

Operating lease liabilities

 

 

(2,552

)

Deferred revenue

 

 

(2,366

)

Deferred tax liability

 

 

(1,011

)

Fair value of net assets acquired

 

$

70,297

 
Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the 908 Devices PAT Portfolio acquisition and their estimated useful lives:

 

 

Useful life

 

Fair Value

 

 

 

 

 

(Amounts in thousands)

 

Customer relationships

 

8 - 9 years

 

$

5,040

 

Developed technology

 

10 - 12 years

 

 

6,910

 

Trademark and tradename

 

13 - 14 years

 

 

1,660

 

 

 

 

 

$

13,610